<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E89C3602-0FB4-4044-A918-58966B8A10B2"><gtr:id>E89C3602-0FB4-4044-A918-58966B8A10B2</gtr:id><gtr:name>University of Reading</gtr:name><gtr:department>Sch of Biological Sciences</gtr:department><gtr:address><gtr:line1>Whiteknights House</gtr:line1><gtr:line2>PO Box 217</gtr:line2><gtr:line4>Reading</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>RG6 6AH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E89C3602-0FB4-4044-A918-58966B8A10B2"><gtr:id>E89C3602-0FB4-4044-A918-58966B8A10B2</gtr:id><gtr:name>University of Reading</gtr:name><gtr:address><gtr:line1>Whiteknights House</gtr:line1><gtr:line2>PO Box 217</gtr:line2><gtr:line4>Reading</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>RG6 6AH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DE77CDB3-E451-40FC-A35D-F2CCFC4C984C"><gtr:id>DE77CDB3-E451-40FC-A35D-F2CCFC4C984C</gtr:id><gtr:firstName>Quentin</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Sattentau</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4CD2AF42-0F0D-4694-A7DF-16C5991E502F"><gtr:id>4CD2AF42-0F0D-4694-A7DF-16C5991E502F</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:otherNames>Martin</gtr:otherNames><gtr:surname>Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0200000"><gtr:id>B98C65AF-9484-4AEC-A332-A4AEF987CF7E</gtr:id><gtr:title>Optimising immunogenicity of the HIV-1 envelope glycoproteins for vaccine use.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0200000</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-09-21</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-05-22</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>635873</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>CNRS</gtr:description><gtr:id>AE84B79B-F1D7-46F2-A68E-A51AEA2ACE49</gtr:id><gtr:impact>Several of the output papers listed are co-authored Experiments are still ongoing Student exchange has occurred</gtr:impact><gtr:outcomeId>A14C07F0DA0-1</gtr:outcomeId><gtr:partnerContribution>Ongoing collaborative experiments on HIV entry; provsion of reagents and assays; co-writing of papers</gtr:partnerContribution><gtr:piContribution>Provision of specialist HIV reagents Particular scientific analysis Co-writing of papers</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BBC</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>F0BCA0CD-6119-4ECF-AABC-5E67E3F85CE4</gtr:id><gtr:impact>I contribute to BBC and other media requests for comment when asked.

I get asked again</gtr:impact><gtr:outcomeId>D7EA24D04B6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A variety of receombinant forms of the HIV envelope protein</gtr:description><gtr:id>7055BFA9-9A7A-413F-AED9-AA8652DC5F11</gtr:id><gtr:impact>I have provided materials for immunisation to other programmes e.g. Eu project EVA and the NIH AIDS reganst programme where it can be obtained via their catalogue</gtr:impact><gtr:outcomeId>5FFA6CD1976</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Candidate vaccines</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6C728823-F60A-45B0-9844-579DCE60E487</gtr:id><gtr:title>Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdfb66698bf12de7c9639a895d0cb7e8"><gtr:id>bdfb66698bf12de7c9639a895d0cb7e8</gtr:id><gtr:otherNames>Law M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>88E5EF18EEB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEAA4565-BF08-4DA8-ADD3-29A477B4939A</gtr:id><gtr:title>The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b78db25f8d82bf2fb7cfaa1f81ead35"><gtr:id>8b78db25f8d82bf2fb7cfaa1f81ead35</gtr:id><gtr:otherNames>Kadlec J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>99A6DD28354</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44A119B8-37BB-4DEA-8613-09C58C00C889</gtr:id><gtr:title>The effect of highly active antiretroviral therapy for HIV on the anti-HCV specific humoral immune response.</gtr:title><gtr:parentPublicationTitle>Journal of medical virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eda4fabbae7507f1928eaae5f776bb1d"><gtr:id>eda4fabbae7507f1928eaae5f776bb1d</gtr:id><gtr:otherNames>Herrero-Mart?nez E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0146-6615</gtr:issn><gtr:outcomeId>486F85B1A76</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70083E0F-AFD5-435D-A3F3-58DE41AC7E83</gtr:id><gtr:title>The molecular basis of HIV capsid assembly--five years of progress.</gtr:title><gtr:parentPublicationTitle>Reviews in medical virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91163857b40a27ab491829a4d34ad509"><gtr:id>91163857b40a27ab491829a4d34ad509</gtr:id><gtr:otherNames>Adamson CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1052-9276</gtr:issn><gtr:outcomeId>3F5009E8C0B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBFC5685-1509-47A1-9C7A-A1FAFCBCB685</gtr:id><gtr:title>The role of myeloid receptors on murine plasmacytoid dendritic cells in induction of type I interferon.</gtr:title><gtr:parentPublicationTitle>International immunopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb4dc5d6e21e4d9952f67ae9d4265860"><gtr:id>cb4dc5d6e21e4d9952f67ae9d4265860</gtr:id><gtr:otherNames>Seeds RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1567-5769</gtr:issn><gtr:outcomeId>WGms1vsReft</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D8CB60A-A512-43A8-A9D0-0DB0000FFF58</gtr:id><gtr:title>Mapping the immune response to the outer domain of a human immunodeficiency virus-1 clade C gp120.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36e6bd83dfd373c441dfe6211f736a6c"><gtr:id>36e6bd83dfd373c441dfe6211f736a6c</gtr:id><gtr:otherNames>Chen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>8245EEF1595</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8EC5827-731D-4740-8868-1C2A2DB57CC9</gtr:id><gtr:title>Cleavage and serum reactivity of the severe acute respiratory syndrome coronavirus spike protein.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8121be001fea3b6cc931b69b4d9268b0"><gtr:id>8121be001fea3b6cc931b69b4d9268b0</gtr:id><gtr:otherNames>Yao YX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>CA2FEE45693</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1427E6B0-0D7F-48C0-A82B-DD28759B7931</gtr:id><gtr:title>Rapid parallel expression in E. Coli and insect cells: analysis of five lef gene products of the Autographa californica multiple nuclear polyhedrosis virus (AcMNPV).</gtr:title><gtr:parentPublicationTitle>Virus genes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b58b1bf841f79914514b2df2a919b1dc"><gtr:id>b58b1bf841f79914514b2df2a919b1dc</gtr:id><gtr:otherNames>Xu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0920-8569</gtr:issn><gtr:outcomeId>00C4252C45C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DFD37B2-083C-4F8B-8758-29842FB2B7ED</gtr:id><gtr:title>HIV Env reduction postreceptor binding: a new target for AIDS treatment?</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94db82086155e35711355b055bc08a38"><gtr:id>94db82086155e35711355b055bc08a38</gtr:id><gtr:otherNames>Fenouillet E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>2EED75F471D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D7C5931-375F-4C78-B440-C6A1A53D1150</gtr:id><gtr:title>Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41dc46d3cf27830c34ab27750cad780e"><gtr:id>41dc46d3cf27830c34ab27750cad780e</gtr:id><gtr:otherNames>Kong L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>ozYYKnCGaoc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9035C8CB-B149-4AC1-BB45-C281D2FA7237</gtr:id><gtr:title>Reintroduction of the 2G12 epitope in an HIV-1 clade C gp120.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36e6bd83dfd373c441dfe6211f736a6c"><gtr:id>36e6bd83dfd373c441dfe6211f736a6c</gtr:id><gtr:otherNames>Chen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>A601C483626</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD7F9D27-ABE9-479A-B450-C879A6E4637D</gtr:id><gtr:title>Glycosaminoglycans and protein disulfide isomerase-mediated reduction of HIV Env.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a74b1231f5de0a2ebd3a9f23bc105b6"><gtr:id>6a74b1231f5de0a2ebd3a9f23bc105b6</gtr:id><gtr:otherNames>Barbouche R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>5FBC6ECEC05</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DCB78CD-BEF3-4414-B201-67E1CF01C0FD</gtr:id><gtr:title>Mapping of domains on HIV envelope protein mediating association with calnexin and protein-disulfide isomerase.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b54898356bf3b40b26b8ff7f2b29cbeb"><gtr:id>b54898356bf3b40b26b8ff7f2b29cbeb</gtr:id><gtr:otherNames>Papandr?ou MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>Sp3qCmyykyq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D7A3EE0-FC5D-4495-B98A-525F47D971DF</gtr:id><gtr:title>Cell entry by enveloped viruses: redox considerations for HIV and SARS-coronavirus.</gtr:title><gtr:parentPublicationTitle>Antioxidants &amp; redox signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94db82086155e35711355b055bc08a38"><gtr:id>94db82086155e35711355b055bc08a38</gtr:id><gtr:otherNames>Fenouillet E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1523-0864</gtr:issn><gtr:outcomeId>18F462B2955</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44C9A076-DDC7-4329-B86B-3DD49F64FCA9</gtr:id><gtr:title>Immunogenicity of the outer domain of a HIV-1 clade C gp120.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36e6bd83dfd373c441dfe6211f736a6c"><gtr:id>36e6bd83dfd373c441dfe6211f736a6c</gtr:id><gtr:otherNames>Chen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>C715CE0B4AC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>834F373F-D216-48FF-A2F2-2C55CFFC23AF</gtr:id><gtr:title>DC-SIGN increases the affinity of HIV-1 envelope glycoprotein interaction with CD4.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c6b6a2655d42f69ae3c3d71f1afa85b"><gtr:id>0c6b6a2655d42f69ae3c3d71f1afa85b</gtr:id><gtr:otherNames>Hijazi K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14769_29_22163292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B620328D-BBF5-4428-A434-A04CD97563E9</gtr:id><gtr:title>Significant redox insensitivity of the functions of the SARS-CoV spike glycoprotein: comparison with HIV envelope.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/972e8c2a8d048e671910519939a2e2b0"><gtr:id>972e8c2a8d048e671910519939a2e2b0</gtr:id><gtr:otherNames>Lavillette D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>AECB23A1B8B</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0200000</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>D8F3A27D-084A-40BB-A046-087DACE23410</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>3.4  Vaccines</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>